{"organizations": [], "uuid": "c31a2e27df61b19db8bdefdba59f6e1f9029c334", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/31/business-wire-smithers-avanza-bioanalytical-services-names-new-business-development-director.html", "country": "US", "domain_rank": 767, "title": "Smithers Avanza Bioanalytical Services Names New Business Development Director", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.113, "site_type": "news", "published": "2018-02-01T00:21:00.000+02:00", "replies_count": 0, "uuid": "c31a2e27df61b19db8bdefdba59f6e1f9029c334"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/31/business-wire-smithers-avanza-bioanalytical-services-names-new-business-development-director.html", "ord_in_thread": 0, "title": "Smithers Avanza Bioanalytical Services Names New Business Development Director", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "GAITHERSBURG, Md.--(BUSINESS WIRE)-- Smithers Avanza , a boutique contract research organization (CRO) supporting the pharmaceutical and chemical industries, has named Robert L. Moore, Ph.D. to the position of Director, Business Development for Bioanalytical Services. The addition of Dr. Moore aligns with Smithers Avanza’s commitment to provide clients with the highest quality of scientific expertise, integrity and customer service as they seek to bring new large-molecule biopharmaceutical products to market.\nThis press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180131006257/en/\nRobert L. Moore, Ph.D., Director, Business Development, Smithers Avanza Bioanalytical Services (Photo: Business Wire)\n“Robert’s unique blend of scientific and industry expertise make him a valuable member of our team and an asset to our clients,” said Ira Dubey, MS, Ph.M., MBA, Executive Vice President Bioanalytical Services. “Dr. Moore’s background will help him to contribute immediately as we seek to take on the additional projects our clients require while we maintain our dedication to quality and service.”\nDr. Moore has over 14 years of academic and industry research experience and has spent the last seven-plus years in business development within the pharmaceutical industry. Prior to joining Smithers Avanza, Dr. Moore served as Sales Director for Cryoport, a life sciences packaging and logistics provider following time spent in Business Development for BioAgilytix Labs. Dr. Moore holds a Ph.D. in Microbiology/Immunology from Boston University and is based in Boston, MA.\nFor more information about the Smithers Avanza portfolio of services, visit http://smithersavanza.com .\nAbout Smithers Avanza\nSmithers Avanza is a contract research organization (CRO) supporting the pharmaceutical industry. Our scientists have expertise in large molecule bioanalysis, assay development, validation, and specimen analysis at our GLP- and GCP-compliant and CLIA-certified laboratory. Smithers Avanza Bioanalytical Services Division supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays . The services focus primarily on development, validation, and specimen analysis for PK/TK, ADA, bioassays, and biomarker assays. Smithers Avanza also offers preclinical toxicology and vaccine testing at our AAALAC accredited facilities.\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180131006257/en/\nSmithers Avanza\nHope Aubin, 508-322-5616\nDirector of Marketing\nhaubin@smithers.com\nSource: Smithers Avanza", "external_links": ["http://www.businesswire.com/news/home/20180131006257/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.smithersavanza.com%2Fbioanalytical&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=large-molecule+biopharmaceutical&index=2&md5=f13c60dc0fda3582085b942c8d360282", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fsmithersavanza.com&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=http%3A%2F%2Fsmithersavanza.com&index=3&md5=da71fc5bcad501ac6fa30f6289537f91", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.smithersavanza.com&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=Smithers+Avanza&index=1&md5=a757449a54f483df130d7bad2423122a", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.smithersavanza.com%2Fbiopharmaceutical-services%2Fbiomarkers%2F&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=biomarker&index=6&md5=e9ac36cabfc0fa28f4f77cc539fd5fc5", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.smithersavanza.com%2Fbiopharmaceutical-services%2Fbioassays%2F&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=bioassays&index=4&md5=7b82b8e914b1ba7e178eb3b67283353d", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.smithersavanza.com%2Fbiopharmaceutical-services%2Fultra-sensitive-immunoassays-2%2F&esheet=51751785&newsitemid=20180131006257&lan=en-US&anchor=high+sensitivity+assays&index=5&md5=b2d4de0723d55b9c5f4a8fd47c8abb15"], "published": "2018-02-01T00:21:00.000+02:00", "crawled": "2018-02-01T02:33:17.003+02:00", "highlightTitle": ""}